Cargando…

Simulation-Based Rapid Development and Implementation of a Novel Barrier Enclosure for Use in COVID-19 Patients: The SplashGuard CG

BACKGROUND: The current COVID-19 pandemic has resulted in over 54,800,000 SARS-CoV-2 infections worldwide with a mortality rate of around 2.5%. As observed in other airborne viral infections such as influenza and SARS-CoV-1, healthcare workers are at high risk for infection when performing aerosol-g...

Descripción completa

Detalles Bibliográficos
Autores principales: François, Tine, Tabone, Laurence, Levy, Arielle, Seguin, Laurence Alix, Touré, Taher, Aubin, Carl Eric, Jouvet, Philippe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7747007/
https://www.ncbi.nlm.nih.gov/pubmed/33381311
http://dx.doi.org/10.1155/2020/3842506
_version_ 1783624908382666752
author François, Tine
Tabone, Laurence
Levy, Arielle
Seguin, Laurence Alix
Touré, Taher
Aubin, Carl Eric
Jouvet, Philippe
author_facet François, Tine
Tabone, Laurence
Levy, Arielle
Seguin, Laurence Alix
Touré, Taher
Aubin, Carl Eric
Jouvet, Philippe
author_sort François, Tine
collection PubMed
description BACKGROUND: The current COVID-19 pandemic has resulted in over 54,800,000 SARS-CoV-2 infections worldwide with a mortality rate of around 2.5%. As observed in other airborne viral infections such as influenza and SARS-CoV-1, healthcare workers are at high risk for infection when performing aerosol-generating medical procedures (AGMP). Additionally, the threats of a global shortage of standard personal protective equipment (PPE) prompted many healthcare workers to explore alternative protective enclosures, such as the “aerosol box” invented by a Taiwanese anesthetist. Our study includes the design process of a protective barrier enclosure and its subsequent clinical implementation in the management of critically ill adults and children infected with SARS-CoV-2. METHODS AND RESULTS: The barrier enclosure was designed for use in our tertiary care facility and named “SplashGuard CG” (CG for Care Givers). The device has been adapted using a multi- and interdisciplinary approach, with collaboration between physicians, respiratory therapists, nurses, and biomechanical engineers. Computer-aided design and simulation sessions throughout the entire process facilitated the rapid and safe implementation of the SplashGuard CG in different settings (intensive care unit, emergency department, and the operating room) during AGMPs such as bag-valve-mask ventilation, nasopharyngeal suctioning, intubation and extubation, and noninvasive ventilation. Indications for use and anticipatory precautions were communicated to all healthcare workers using the SplashGuard CG. The entire process was completed within one month. CONCLUSION: The rapid design, development, and clinical implementation of a new barrier enclosure, the “SplashGuard CG,” was feasible in this time of crisis thanks to close collaboration between medical and engineering teams and the use of recurring simulation sessions to test and improve the initial prototypes. Following this accelerated process, it is necessary to maintain team skills, monitor any undesirable effects, and evaluate and continuously improve this new device.
format Online
Article
Text
id pubmed-7747007
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-77470072020-12-29 Simulation-Based Rapid Development and Implementation of a Novel Barrier Enclosure for Use in COVID-19 Patients: The SplashGuard CG François, Tine Tabone, Laurence Levy, Arielle Seguin, Laurence Alix Touré, Taher Aubin, Carl Eric Jouvet, Philippe Crit Care Res Pract Research Article BACKGROUND: The current COVID-19 pandemic has resulted in over 54,800,000 SARS-CoV-2 infections worldwide with a mortality rate of around 2.5%. As observed in other airborne viral infections such as influenza and SARS-CoV-1, healthcare workers are at high risk for infection when performing aerosol-generating medical procedures (AGMP). Additionally, the threats of a global shortage of standard personal protective equipment (PPE) prompted many healthcare workers to explore alternative protective enclosures, such as the “aerosol box” invented by a Taiwanese anesthetist. Our study includes the design process of a protective barrier enclosure and its subsequent clinical implementation in the management of critically ill adults and children infected with SARS-CoV-2. METHODS AND RESULTS: The barrier enclosure was designed for use in our tertiary care facility and named “SplashGuard CG” (CG for Care Givers). The device has been adapted using a multi- and interdisciplinary approach, with collaboration between physicians, respiratory therapists, nurses, and biomechanical engineers. Computer-aided design and simulation sessions throughout the entire process facilitated the rapid and safe implementation of the SplashGuard CG in different settings (intensive care unit, emergency department, and the operating room) during AGMPs such as bag-valve-mask ventilation, nasopharyngeal suctioning, intubation and extubation, and noninvasive ventilation. Indications for use and anticipatory precautions were communicated to all healthcare workers using the SplashGuard CG. The entire process was completed within one month. CONCLUSION: The rapid design, development, and clinical implementation of a new barrier enclosure, the “SplashGuard CG,” was feasible in this time of crisis thanks to close collaboration between medical and engineering teams and the use of recurring simulation sessions to test and improve the initial prototypes. Following this accelerated process, it is necessary to maintain team skills, monitor any undesirable effects, and evaluate and continuously improve this new device. Hindawi 2020-12-17 /pmc/articles/PMC7747007/ /pubmed/33381311 http://dx.doi.org/10.1155/2020/3842506 Text en Copyright © 2020 Tine François et al. https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
François, Tine
Tabone, Laurence
Levy, Arielle
Seguin, Laurence Alix
Touré, Taher
Aubin, Carl Eric
Jouvet, Philippe
Simulation-Based Rapid Development and Implementation of a Novel Barrier Enclosure for Use in COVID-19 Patients: The SplashGuard CG
title Simulation-Based Rapid Development and Implementation of a Novel Barrier Enclosure for Use in COVID-19 Patients: The SplashGuard CG
title_full Simulation-Based Rapid Development and Implementation of a Novel Barrier Enclosure for Use in COVID-19 Patients: The SplashGuard CG
title_fullStr Simulation-Based Rapid Development and Implementation of a Novel Barrier Enclosure for Use in COVID-19 Patients: The SplashGuard CG
title_full_unstemmed Simulation-Based Rapid Development and Implementation of a Novel Barrier Enclosure for Use in COVID-19 Patients: The SplashGuard CG
title_short Simulation-Based Rapid Development and Implementation of a Novel Barrier Enclosure for Use in COVID-19 Patients: The SplashGuard CG
title_sort simulation-based rapid development and implementation of a novel barrier enclosure for use in covid-19 patients: the splashguard cg
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7747007/
https://www.ncbi.nlm.nih.gov/pubmed/33381311
http://dx.doi.org/10.1155/2020/3842506
work_keys_str_mv AT francoistine simulationbasedrapiddevelopmentandimplementationofanovelbarrierenclosureforuseincovid19patientsthesplashguardcg
AT tabonelaurence simulationbasedrapiddevelopmentandimplementationofanovelbarrierenclosureforuseincovid19patientsthesplashguardcg
AT levyarielle simulationbasedrapiddevelopmentandimplementationofanovelbarrierenclosureforuseincovid19patientsthesplashguardcg
AT seguinlaurencealix simulationbasedrapiddevelopmentandimplementationofanovelbarrierenclosureforuseincovid19patientsthesplashguardcg
AT touretaher simulationbasedrapiddevelopmentandimplementationofanovelbarrierenclosureforuseincovid19patientsthesplashguardcg
AT aubincarleric simulationbasedrapiddevelopmentandimplementationofanovelbarrierenclosureforuseincovid19patientsthesplashguardcg
AT jouvetphilippe simulationbasedrapiddevelopmentandimplementationofanovelbarrierenclosureforuseincovid19patientsthesplashguardcg